As filed with the Securities and Exchange Commission on November 3, 2023
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-3
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
Vir Biotechnology, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware |
|
81-2730369 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification Number) |
1800 Owens Street, Suite 900
San Francisco, California 94158
(415) 906-4324
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
Marianne De Backer, M.Sc., Ph.D., MBA
Chief Executive Officer
1800 Owens Street, Suite 900
San Francisco, California 94158
(415) 906-4324
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copy to:
|
|
|
Vanina de Verneuil
EVP, General Counsel and Corporate Secretary
1800 Owens Street, Suite 900
San Francisco, California 94158
(415) 906-4324 |
|
Cynthia T. Mazareas
Craig Hilts Wilmer Cutler
Pickering Hale and Dorr LLP 60 State Street
Boston, Massachusetts 02109
(617) 526-6000 |
Approximate date of commencement of proposed sale to the public: From time to time after this
registration statement becomes effective.
If the only securities being registered on this Form are being offered pursuant to dividend or
interest reinvestment plans, please check the following box: ☐
If any of the securities being registered on this Form are to be
offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box: ☒
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the
following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this
Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following
box. ☒
If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed
to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting
company, and emerging growth company in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
Large accelerated filer ☒ |
|
|
|
Accelerated filer ☐ |
|
|
|
Non-accelerated filer ☐ |
|
|
|
Smaller reporting company ☐ |
|
|
|
|
Emerging growth company ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐